Twist Bioscience Corporation

TWST

$5.45B

Mid Cap

NASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaSOUTH SAN FRANCISCO979 employees

Drugs in Pipeline

Phase 3 Programs

Upcoming Catalysts

Next Catalyst

Aug 3, 2026

25d

Market Overview

Stock performance and key metrics

TWST News

Catalyst Timeline

1 upcoming, 0 past

No catalysts found.

1 more catalyst beyond 14 days

Start a 48-hour free trial to see all upcoming catalysts

Pro

How TWST's past catalysts played out

earningsMay 2026-7%earningsFeb 2026+14%earningsJan 2026+8%earningsAug 2025-10%earningsMay 2025-8%earningsNov 2024+12%earningsAug 2024-19%earningsFeb 2024+10%

Drug Pipeline

No drugs found in this phase.

📑

Catalyst DossierPRO

The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.

→

Catalyst Verdict

Full breakdown — the signals behind the verdict

Market-Implied Move

Regulatory Approvals

Frequently asked questions

When is Twist Bioscience Corporation's next FDA catalyst?→

Twist Bioscience Corporation's (TWST) next tracked catalyst is a Earnings expected August 3, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track TWST biotech catalysts?→

Add TWST to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Twist Bioscience Corporation's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply